Vasopressin for treatment of shock following aprotinin administration

Canadian Journal of Anesthesia

Volumn 51, Issue 2, 2004, Pages 169-172

  Williams, Stephen R ^a   Denault, André Y ^a   Pellerin, Michel ^a   Martineau, Raymond ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOCAPROIC ACID; APROTININ; GENTAMICIN; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; IPRATROPIUM BROMIDE; KETAMINE; METFORMIN; METHYLPREDNISOLONE; MIDAZOLAM; MILRINONE; MORPHINE; PANCURONIUM; PHENYLEPHRINE; SALBUTAMOL; SUFENTANIL; VANCOMYCIN; VASOPRESSIN;

ADULT; ANAPHYLACTIC SHOCK; ARTICLE; BLOOD PRESSURE REGULATION; BRONCHOSPASM; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; DRUG RESPONSE; ENDOCARDITIS; FEMALE; HEART SURGERY; HEART VALVE PROSTHESIS; HUMAN; HYPERTENSION; HYPOTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VASODILATATION;

EID: 1942504369     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018778     Document Type: Article

References (14)

1. Dunser MW, Mayr AJ, Ulmer H, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001; 93: 7-13.
2. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA 3rd. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487-93.
3. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998; 116: 973-80.
4. Morales DL, Gregg D, Helman DN, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 2000; 69: 102-6.
5. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289-91.
6. Lemmer JH Jr, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 1994; 107: 543-51.
7. Levy JH, Pifarre R, Schaff HV, et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995; 92: 2236-44.
8. Dietrich W, Spath P, Ebell A, Richter JA. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 1997; 113: 194-201.
9. Diefenbach C, Abel M, Limpers B, et al. Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery. Anesth Analg 1995; 80: 830-1.
10. Dietrich W, Spath P, Zuhlsdorf M, et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 2001; 95: 64-71.
11. Anonymous. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: section 1: introduction to ACLS 2000: overview of recommended changes in ACLS from the guidelines 2000 conference. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102(8 Suppl): I86-9.
12. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996; 124: 1061-4.
13. Talbot MP, Tremblay I, Denault AY, Belisle S. Vasopressin for refractory hypotension during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2000; 120: 401-2.
14. Tsuda A, Tanaka KA, Huraux C, et al. The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. Anesth Analg 2001; 93: 1453-9.